Briefing
Urine cell-free RNA for bladder cancer detection and treatment response prediction.
95% sensitivity at 90% specificity for detecting localized bladder cancer.
- Design: Detection, MRD, and BCG-versus-chemotherapy response prediction in bladder cancer; also transcripts from prostate and kidney cancers noted.
- n: 683 urine samples from patients with cancer and controls
- Assay: uRARE-seq (urine random priming and affinity capture of cell-free RNA fragments for enrichment analysis by sequencing)
Nat Med. Published 2 October 2026. Open access on the Nature page. Do not use PMC13743215 (wrong article).PubMed 42827132